Pharmaron Beijing Co., Ltd. - Laporan Laba Rugi (TTM)

Pharmaron Beijing Co., Ltd.
HK ˙ SEHK ˙ CNE100003PG4
HK$ 23.36 ↑1.86 (8.65%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Pharmaron Beijing Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 4,717 5,134 5,664 6,226 6,849 7,444 8,057 8,793 9,545 10,266 10,887 11,272 11,424 11,538 11,485 11,502 11,795 12,276 12,704 13,112
Change (%) 8.84 10.33 9.93 10.01 8.68 8.24 9.13 8.55 7.56 6.05 3.53 1.35 1.00 -0.46 0.15 2.54 4.08 3.49 3.21
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 2,912 3,215 3,549 3,912 4,345 4,768 5,203 5,688 6,106 6,502 6,844 7,081 7,282 7,422 7,472 7,561 7,771 8,091 8,349 8,612
Change (%) 10.39 10.38 10.24 11.08 9.72 9.13 9.33 7.35 6.47 5.26 3.47 2.84 1.92 0.67 1.19 2.77 4.13 3.18 3.16
% of Revenue 61.74 62.62 62.65 62.83 63.44 64.05 64.57 64.69 63.97 63.33 62.86 62.82 63.75 64.33 65.06 65.73 65.88 65.91 65.72 65.68
Gross Operating Profit 1,805 1,919 2,115 2,314 2,504 2,676 2,854 3,104 3,439 3,764 4,044 4,191 4,141 4,116 4,013 3,942 4,024 4,184 4,355 4,500
Change (%) 6.34 10.23 9.41 8.20 6.87 6.66 8.76 10.76 9.48 7.42 3.63 -1.18 -0.61 -2.50 -1.78 2.10 3.97 4.08 3.33
% of Revenue 38.26 37.38 37.35 37.17 36.56 35.95 35.43 35.31 36.03 36.67 37.14 37.18 36.25 35.67 34.94 34.27 34.12 34.09 34.28 34.32
SG&A 691 761 820 856 954 1,033 1,147 1,355 1,533 1,749 1,887 1,950 1,966 1,895 1,883 1,895 1,888 1,886 1,903 1,922
Change (%) 10.08 7.75 4.46 11.43 8.24 11.08 18.16 13.10 14.10 7.88 3.32 0.86 -3.62 -0.66 0.64 -0.37 -0.08 0.90 0.98
% of Revenue 14.65 14.82 14.47 13.75 13.93 13.87 14.24 15.41 16.06 17.04 17.33 17.30 17.21 16.43 16.39 16.47 16.00 15.36 14.98 14.66
R&D 89 105 113 127 146 152 162 171 219 282 320 381 402 448 465 474 484 469 498 512
Change (%) 18.44 7.73 11.64 15.35 3.85 6.95 5.33 28.31 28.69 13.17 19.19 5.46 11.62 3.74 1.90 2.08 -3.00 6.10 2.82
% of Revenue 1.89 2.05 2.00 2.04 2.13 2.04 2.01 1.94 2.30 2.75 2.93 3.38 3.52 3.89 4.05 4.12 4.10 3.82 3.92 3.90
OpEx 3,704 4,114 4,501 4,925 5,488 5,996 6,571 7,277 7,923 8,600 9,110 9,475 9,696 9,848 9,915 10,029 10,278 10,557 10,860 11,181
Change (%) 11.07 9.42 9.42 11.43 9.26 9.58 10.74 8.89 8.54 5.93 4.00 2.34 1.57 0.68 1.15 2.49 2.71 2.88 2.96
% of Revenue 78.52 80.13 79.47 79.11 80.13 80.55 81.55 82.76 83.01 83.77 83.67 84.06 84.88 85.36 86.34 87.19 87.14 85.99 85.49 85.27
Operating Income 1,013 1,020 1,163 1,301 1,361 1,448 1,486 1,516 1,622 1,667 1,778 1,797 1,728 1,690 1,569 1,473 1,517 1,719 1,844 1,931
Change (%) 0.69 13.98 11.89 4.65 6.35 2.69 2.00 6.96 2.77 6.66 1.11 -3.86 -2.21 -7.12 -6.11 2.94 13.35 7.24 4.73
% of Revenue 21.48 19.87 20.53 20.89 19.87 19.45 18.45 17.24 16.99 16.23 16.33 15.94 15.12 14.64 13.66 12.81 12.86 14.01 14.51 14.73
Interest Expense -38 -24 -21 -26 -55 -83 -117 -149 -159 -167 -175 -175 -177 -182 -206 -231 -245 -244 -217 -251
Change (%) -36.56 -11.52 24.39 109.70 50.89 40.55 27.21 6.92 5.36 4.33 0.31 0.98 3.03 13.04 12.36 5.75 -0.41 -10.95 15.86
% of Revenue -0.80 -0.46 -0.37 -0.42 -0.80 -1.12 -1.45 -1.69 -1.66 -1.63 -1.60 -1.55 -1.55 -1.58 -1.79 -2.01 -2.07 -1.99 -1.71 -1.92
Net Income 1,008 1,172 1,317 1,258 1,423 1,661 1,664 1,682 1,582 1,375 1,474 1,575 1,553 1,601 1,483 1,928 1,884 1,793 1,868 1,381
Change (%) 16.32 12.31 -4.44 13.12 16.69 0.19 1.04 -5.92 -13.11 7.21 6.89 -1.44 3.13 -7.35 30.00 -2.31 -4.80 4.18 -26.07
% of Revenue 21.37 22.84 23.25 20.21 20.78 22.31 20.66 19.12 16.57 13.39 13.54 13.98 13.59 13.88 12.92 16.77 15.97 14.61 14.71 10.53

Source: Capital IQ

Other Listings
DE:17Q1 € 2.46
US:PHBBF
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista